GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Loans Receivable

ReNeuron Group (ReNeuron Group) Loans Receivable : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Loans Receivable?

ReNeuron Group's Loans Receivable for the quarter that ended in Sep. 2023 was $0.00 Mil.


ReNeuron Group Loans Receivable Historical Data

The historical data trend for ReNeuron Group's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Loans Receivable Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ReNeuron Group Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


ReNeuron Group Loans Receivable Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (ReNeuron Group) Business Description

Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group (ReNeuron Group) Headlines

From GuruFocus

ReNeuron Signs New Exosome Research Collaboration

By PRNewswire PRNewswire 06-25-2020

ReNeuron Group (RENE): Extension Trial to Produce Data in Q122

By ACCESSWIRE ACCESSWIRE 10-11-2021

ReNeuron Expands Exosome IP Portfolio with Key Patent Grants

By PRNewswire PRNewswire 07-16-2019

ReNeuron Update Regarding COVID-19

By PRNewswire PRNewswire 04-07-2020

ReNeuron Provides Program and Regulatory Approvals Update

By PRNewswire PRNewswire 06-17-2020

Edison Issues Update on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 06-23-2020

Edison Issues Outlook on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 08-26-2020

ReNeuron Provides Business Update and Results Notification

By PRNewswire PRNewswire 05-08-2019